Comments

Palvella Therapeutics

Q: What sector and industry does Palvella Therapeutics (PVLA) operate in?

Palvella Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

PVLANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Palvella Therapeutics (PVLA) Forecast

News Earnings Palvella Therapeutics (PVLA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Palvella Therapeutics (NASDAQ:PVLA) Stock Quotes, Forecast and News Summary

Palvella Therapeutics Stock (NASDAQ: PVLA) stock price, news, charts, stock research, profile.

Open	$12.10
Close	-
Volume / Avg.	29.45K / 34.46K
Day Range	$11.86 - $12.32
52 Wk Range	11.60 - 13.29
Market Cap	$134.66M
P/E Ratio	6.03
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$12.10
Close	-
Volume / Avg.	29.45K / 34.46K
Day Range	$11.86 - $12.32
52 Wk Range	11.60 - 13.29
Market Cap	$134.66M
P/E Ratio	6.03
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Palvella Therapeutics (PVLA) stock?

You can purchase shares of Palvella Therapeutics (NASDAQ:PVLA) through any online brokerage.

View our list of the best stock brokerages

Who are Palvella Therapeutics (PVLA) competitors?

There are no as such competitors for Palvella Therapeutics.

What is the forecast, or price target, for Palvella Therapeutics (PVLA) stock?

Palvella Therapeutics has a consensus price target of $38.00.

What is the current price for Palvella Therapeutics (PVLA)?

The stock price for Palvella Therapeutics (NASDAQ: PVLA) is $12.6 last updated December 26, 2024 at 9:18 AM EST.

Does Palvella Therapeutics (PVLA) pay a dividend?

There are no upcoming dividends for Palvella Therapeutics.

When is Palvella Therapeutics (NASDAQ:PVLA) reporting earnings?

Palvella Therapeutics’s Q4 earnings are confirmed for Saturday, February 15, 2025.

Is Palvella Therapeutics (PVLA) going to split?

There is no upcoming split for Palvella Therapeutics.

What sector and industry does Palvella Therapeutics (PVLA) operate in?

Palvella Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.